Carboxylesterases - Ddetoxifying enzymes and targets for drug therapy

被引:125
作者
Potter, PM
Wadkins, RM
机构
[1] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA
[2] Univ Mississippi, Dept Chem & Biochem, University, MS 38677 USA
关键词
carboxylesterase; drug metabolism; enzyme structure; inhibitor;
D O I
10.2174/092986706776360969
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carboxylesterases (CE) are ubiquitous enzymes responsible for the detoxification of xenobiotics. Many therapeutically useful drugs are metabolized by these proteins which impacts upon the efficiency of drug treatment. In some instances, CEs convert inactive prodrugs to active metabolites, a process that is essential for biological activity. Such compounds include the anticancer agents CPT-11 (3) and capecitabine (4), the antibiotics Ceftin (9) and Vantin, as well as the illicit street drug heroin (6). However, more commonly, CEs hydrolyze many esteriried drugs to inactive products that are then excreted. Agents such as flestolol (11). meperidine (5), lidocaine (8) and cocaine (7). are all hydrolyzed and inactivated by these enzymes. Therefore the efficacy of esterified drugs will be dependent upon the distribution and catalytic activity of different CEs. In this review. we examine the structural aspects of CEs and their roles in drug detoxification and propose that modulation of CE activity may allow for improvements in, and potentiation of, drug efficacy.
引用
收藏
页码:1045 / 1054
页数:10
相关论文
共 59 条
[1]   PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS [J].
ABIGERGES, D ;
CHABOT, GG ;
ARMAND, JP ;
HERAIT, P ;
GOUYETTE, A ;
GANDIA, D .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :210-221
[2]   NONOXIDATIVE ENZYMES IN METABOLISM OF INSECTICIDES [J].
AHMAD, S ;
FORGASH, AJ .
DRUG METABOLISM REVIEWS, 1976, 5 (01) :141-164
[3]   Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine [J].
Alexson, SEH ;
Diczfalusy, M ;
Halldin, M ;
Swedmark, S .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) :643-647
[4]  
[Anonymous], 1972, Enzyme inhibitors as substrates-Interactions of esterases with esters of organophosphorus and carbamic acids
[5]   Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme [J].
Bencharit, S ;
Morton, CL ;
Xue, Y ;
Potter, PM ;
Redinbo, MR .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (05) :349-356
[6]   Structural insights into CPT-11 activation by mammalian carboxylesterases [J].
Bencharit, S ;
Morton, CL ;
Howard-Williams, EL ;
Danks, MK ;
Potter, PM ;
Redinbo, MR .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (05) :337-342
[7]   Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition [J].
Bencharit, S ;
Morton, CL ;
Hyatt, JL ;
Kuhn, P ;
Danks, MK ;
Potter, PM ;
Redinbo, MR .
CHEMISTRY & BIOLOGY, 2003, 10 (04) :341-349
[8]  
Berg D, 1998, SEMIN ONCOL, V25, P53
[9]   Target-related affinity profiling: Telik's lead discovery technology [J].
Beroza, P ;
Damodaran, K ;
Lum, RT .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (04) :371-381
[10]   Chemoproteomics as a basis for post-genomic drug discovery [J].
Beroza, P ;
Villar, HO ;
Wick, MM ;
Martin, GR .
DRUG DISCOVERY TODAY, 2002, 7 (15) :807-814